Creo Medical, an emerging leader in electrosurgery, has completed its latest financing round totalling USD8.45m, including new investor Pentax Medical (HOYA Group). Participants in this financing round also include existing investors Finance Wales, the Angel CoFund and individual angel investors. To date, Creo Medical has secured investment totaling USD20.7 million.
Independent fund and corporate services provider Crestbridge is to expand into the Cayman Islands in response to continued growth and client demand. Subject to regulatory approvals from the Cayman Islands Monetary Authority, Crestbridge plans to offer a range of governance services to the international funds community with the office,
Private equity firm Thoma Bravo has hired Jennifer James (pictured) to serve as Director, Head of Investor Relations & Marketing. In this newly created role, James will lead Thoma Bravo’s efforts to serve the needs of the firm’s existing investors, introduce new investors to Thoma Bravo and oversee its industry
Clearsight Advisors, an independent merchant banking firm providing M&A and capital raising solutions to growth oriented Business & Technology services companies, has opened a new office in Dallas, Texas. The new location, Clearsight’s first office outside of its headquarters location in Metropolitan Washington, DC, will be led by Clearsight Managing
Arlington Capital Partners has acquired Ontario Systems (OS), a provider of revenue cycle management (RCM) software and solutions to healthcare providers, outsourced RCM and accounts receivable management (ARM) firms, and government clients. For more than 30 years, Ontario Systems has served healthcare providers and their business offices with software, technology
Mid-market private equity firm LDC has backed the management buyout of UK based shower brand Aqualisa for an undisclosed price from Sankaty Advisors, LLC, the credit affiliate of Bain Capital, and RBS. Aqualisa designs and manufactures a range of digital, mixer and electric showers and accessories, retailing through builders' merchants,
i2 Capital, a specialty finance firm that sponsors structured investment vehicles for the impact investment marketplace, has appointed Jonathan Stearns (pictured) and Rob Wallace as Partners. Stearns will serving as Chief Investment Officer and Wallace as Chief Government Affairs Officer. i2 Capital has also closed a series A funding round
CVC Capital Partners is opening an office in Poland, extending its global network to 23 offices. Krzysztof Krawczyk (pictured), a seasoned Central and Eastern European (CEE) investor, will join CVC in October as Head of Poland and will be based in Warsaw. The office opening follows the recent agreement to
In the face of volatility in the surrounding European continent, Germany has remained relatively stable and attractive to many private equity investors. Here, Preqin provides the latest statistics for German fundraising and deals, as well as details of the largest transactions of 2015 YTD. Read the full factsheet here, featuring
Forbion Capital Partners’ portfolio company, Dezima Pharma, a biotechnology company developing innovative drugs to treat dyslipidemic patients suffering from cardiovascular disease (CVD), is to be acquired by Amgen, Inc. Amgen has agreed to acquire all outstanding shares of Dezima for up to USD1.55 billion from Forbion and other current shareholders,
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
